Skip to main content
Livermore
Livermore
ZHEN

Janux Therapeutics, Inc.

JANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001817713

No open-market purchases or sales by Janux Therapeutics, Inc. insiders were filed in the last 90 days; 197 institutions reported holding it in 13F filings for Q2 2026, worth $933.4M in total; no superinvestor holds it.

13F holders, Q4 2022

Institutional positions in Janux Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
50
+1 vs. Q3 2022
Shares held
29.0M
−604.2K (−2.0%) vs. Q3 2022
Total value
$381.3M
−$18.9M (−4.7%) vs. Q3 2022
New holders
9
16 more added
Sold out
8
12 more reduced

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting JANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 50 institutions
Q1 2021: 0 institutionsQ2 2021: 30 institutionsQ3 2021: 45 institutionsQ4 2021: 46 institutionsQ1 2022: 47 institutionsQ2 2022: 44 institutionsQ3 2022: 49 institutionsQ4 2022: 50 institutionsQ1 2023: 48 institutionsQ2 2023: 54 institutionsQ3 2023: 57 institutionsQ4 2023: 64 institutionsQ1 2024: 121 institutionsQ2 2024: 155 institutionsQ3 2024: 160 institutionsQ4 2024: 216 institutionsQ1 2025: 181 institutionsQ2 2025: 174 institutionsQ3 2025: 174 institutionsQ4 2025: 176 institutionsQ1 2026: 190 institutionsQ2 2026: 197 institutions
Value heldQ4 2022: $381.3M
Q1 2021: $0Q2 2021: $614.5MQ3 2021: $571.2MQ4 2021: $541.6MQ1 2022: $407.1MQ2 2022: $353.0MQ3 2022: $400.3MQ4 2022: $381.3MQ1 2023: $369.5MQ2 2023: $362.1MQ3 2023: $354.0MQ4 2023: $359.5MQ1 2024: $1.59BQ2 2024: $1.87BQ3 2024: $2.07BQ4 2024: $3.43BQ1 2025: $1.81BQ2 2025: $1.51BQ3 2025: $1.59BQ4 2025: $860.0MQ1 2026: $827.8MQ2 2026: $933.4M
Institutions holding JANX and their total value by quarter
QuarterHoldersValue
Q2 2026197$933.4M
Q1 2026190$827.8M
Q4 2025176$860.0M
Q3 2025174$1.59B
Q2 2025174$1.51B
Q1 2025181$1.81B
Q4 2024216$3.43B
Q3 2024160$2.07B
Q2 2024155$1.87B
Q1 2024121$1.59B
Q4 202364$359.5M
Q3 202357$354.0M
Q2 202354$362.1M
Q1 202348$369.5M
Q4 202250$381.3M
Q3 202249$400.3M
Q2 202244$353.0M
Q1 202247$407.1M
Q4 202146$541.6M
Q3 202145$571.2M
Q2 202130$614.5M
Q1 20210$0

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Janux Therapeutics, Inc.; share changes are against Q3 2022.

Institutions holding JANX in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Credit Suisse AG1$130.00%−93−98.9%Reduced
McElhenny Sheffield Capital Management, LLC17$2240.00%+17New
Simplex Trading, LLC100$1.00K0.00%+100New
TCI Wealth Advisors, Inc.91$1.20K0.00%+91New
Crewe Advisors LLC115$1.51K0.00%00.0%Unchanged
UBS Group AG213$2.81K0.00%+213New
Citigroup Inc397$5.23K0.00%−588−59.7%Reduced
Tower Research Capital LLC (TRC)1,341$18.0K0.00%+186+16.1%Added
Metropolitan Life Insurance Co1,382$18.2K0.00%00.0%Unchanged
Ameritas Investment Partners, Inc.1,014$20.8K0.00%00.0%Unchanged
Legal & General Group Plc1,742$22.8K0.00%00.0%Unchanged
Royal Bank of Canada2,181$28.0K0.00%+1,947+832.1%Added
Amalgamated Bank2,182$29.0K0.00%00.0%Unchanged
Barclays PLC4,608$60.7K0.00%+3,880+533.0%Added
California State Teachers Retirement System6,851$90.2K0.00%+77+1.1%Added
SG Americas Securities, LLC7,902$104.0K0.00%+7,902New
American International Group, Inc.8,118$106.9K0.00%−29−0.4%Reduced
Deutsche Bank AG8,213$108.2K0.00%+114+1.4%Added
MetLife Investment Management10,614$139.8K0.00%00.0%Unchanged
HRT Financial LP12,298$161.0K0.00%+12,298New
New York State Common Retirement Fund13,235$174.3K0.00%−24−0.2%Reduced
Goldman Sachs Group Inc14,603$192.3K0.00%+556+4.0%Added
Morgan Stanley17,484$230.3K0.00%−123,996−87.6%Reduced
Bank of America Corp18,498$243.6K0.00%+3,341+22.0%Added
Parkwood LLC21,469$283.0K0.06%−11,883−35.6%Reduced
Rhumbline Advisers25,691$338.0K0.00%+111+0.4%Added
Ergoteles LLC31,563$415.7K0.02%+31,563New
Millennium Management LLC39,910$526.0K0.00%+39,910New
Charles Schwab Investment Management Inc47,690$628.1K0.00%+1,127+2.4%Added
DekaBank Deutsche Girozentrale49,500$668.0K0.00%00.0%Unchanged
Bank of New York Mellon Corp53,505$704.7K0.00%+3,412+6.8%Added
Vident Investment Advisory, LLC57,514$757.5K0.03%+57,514New
Nuveen Asset Management, LLC60,717$799.0K0.00%−12,160−16.7%Reduced
JPMorgan Chase & Co103,783$1.37M0.00%−1,270−1.2%Reduced
Northern Trust Corp139,728$1.84M0.00%+3,364+2.5%Added
State Street Corp283,110$3.73M0.00%+18,903+7.2%Added
Geode Capital Management, LLC339,797$4.47M0.00%+5,276+1.6%Added
Samsara BioCapital, LLC360,414$4.75M1.02%00.0%Unchanged
5AM Venture Management, LLC446,266$5.88M1.58%00.0%Unchanged
Woodline Partners LP505,364$6.66M0.09%+105,183+26.3%Added
Adage Capital Partners GP, L.L.C.701,066$9.23M0.02%+301,066+75.3%Added
Vanguard Group Inc754,620$9.94M0.00%−5,854−0.8%Reduced
BlackRock Inc.1,103,055$14.5M0.00%−147,293−11.8%Reduced
EcoR1 Capital, LLC1,421,319$18.7M0.57%00.0%Unchanged
BVF Inc1,470,334$19.4M0.82%00.0%Unchanged
Janus Henderson Group PLC1,837,791$24.2M0.02%−122,253−6.2%Reduced
Citadel Advisors LLC1,854,811$24.4M0.03%+1,595+0.1%Added
OrbiMed Advisors LLC2,836,386$37.4M0.72%00.0%Unchanged
FMR LLC5,605,860$73.8M0.01%−641,532−10.3%Reduced
Ra Capital Management, L.P.8,670,644$114.2M2.32%00.0%Unchanged
Cerity Partners LLC0$00.00%−105,933−100.0%Sold out
Chicago Partners Investment Group LLC0$00.00%−10,621−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−12,182−100.0%Sold out
BNP Paribas Arbitrage, SA0$00.00%−7,638−100.0%Sold out
China Universal Asset Management Co., Ltd.0$00.00%−390−100.0%Sold out
Daiwa Securities Group Inc.0$00.00%−121−100.0%Sold out
Wells Fargo & Company0$00.00%−45−100.0%Sold out
Capital Advisors, Ltd. LLC0$00.00%−90−100.0%Sold out